Drug · DIN 02417200
NESINA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 13, 2014; first marketed May 13, 2014.
- Drug Identification Number (DIN)
- 02417200
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Alogliptin A10BH04
- Class
- Human
- Record last updated
- September 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALOGLIPTIN (ALOGLIPTIN BENZOATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 27, 2013: NOC 14956New Drug Submission (NDS)
Other DINs named NESINA
- DIN 02417189 · Marketed
- DIN 02417197 · Marketed